Identification of Src transformation fingerprint in human colon cancer
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
We used a classical rodent model of transformation to understand the transcriptional processes, and hence the molecular and cellular events a given cell undergoes when progressing from a normal to a transformed phenotype. Src activation is evident in 80% of human colon cancer, yet the myriad of cellular processes effected at the level of gene expression has yet to be fully documented. We identified a Src 'transformation fingerprint' within the gene expression profiles of Src-transformed rat 3Y1 fibroblasts demonstrating a progression in transformation characteristics. To evaluate the role of this gene set in human cancer development and progression, we extracted the orthologous genes present on the Affymetrix Hu95A GeneChip (12k named genes) and compared expression profiles between the Src-induced rodent cell line model of transformation and staged colon tumors where Src is known to be activated. A similar gene expression pattern between the cell line model and staged colon tumors for components of the cell cycle, cytoskeletal associated proteins, transcription factors and lysosomal proteins suggests the need for co-regulation of several cellular processes in the progression of cancer. Genes not previously implicated in tumorigenesis were detected, as well as a set of 14 novel, highly conserved genes with here-to-fore unknown function. These studies define a set of transformation associated genes whose up-regulation has implications for understanding Src mediated transformation and strengthens the role of Src in the development and progression of human colon cancer. Supportive Supplemental Data can be viewed at http://pga.tigr.org/PGApubs.shtml.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a conserved “Src transformation fingerprint” has been identified in human CRC, which revealed unique expression patterns encoding for transcription factors (TFs), heat shock proteins, cell growth proteins, proliferation and other cellular components.21”
From The molecular rationale of Src inhibition in colorectal carcinomas (2014) · cites this paper as [21]
Citations
Cites
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184 · cited 1×
“…in the pattern with which their expression varied across the Src-transfected cell lines, we applied two-dimensional hierarchical clustering (Eisen et al., 1998) to log2-transformed, median centered, normalized expression ratios for each gene using a Pearson correlation coefficient distance…”
MethodExploring the Metabolic and Genetic Control of Gene Expression on a Genomic Scale
DeRisi, J. L., Iyer, V. R., & Brown, P. O. (1997) · Science · doi:10.1126/science.278.5338.680 · Cited by 4,456 · cited 7×
“Src-regulated genes that overlap genes in colon cancer In order to determine whether the transformationassociated genes identified using the rat fibroblast model are relevant in human colon cancer, we compared expression ratios of orthologous genes present in both the rat cDNA array and Affymetrix Hu95A GeneChipTM.”
MethodInfluentialCELLULAR FUNCTIONS REGULATED BY SRC FAMILY KINASES
Thomas, S. M., & Brugge, J. S. (1997) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.13.1.513 · Cited by 2,498 · cited 2×
“Dysregulation of Src via post-translational modifications or genetic alterations leads to constitutive kinase activity and cellular transformation (reviewed in Bjorge et al., 1995; Brown and Cooper, 1996; Jove and Hanafusa, 1987; Martin, 2001; Taylor and Shalloway, 1996; Thomas and Brugge, 1997).”
BackgroundSingular value decomposition for genome-wide expression data processing and modeling
Alter, O., Brown, P. O., & Botstein, D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.18.10101 · Cited by 1,971 · cited 4×
“PCA is a mathematical technique used to reduce the dimensionality of our data by identifying subsets of gene expression profiles that were responsible for the majority of variance among the cell lines.”
MethodInfluentialClustering Gene Expression Patterns
Ben-Dor, A., Shamir, R., & Yakhini, Z. (1999) · Journal of Computational Biology · doi:10.1089/106652799318274 · Cited by 1,203 · cited 1×
“This cluster partitioned consistently by k-means and CAST (Ben-Dor et al., 1999).”
MethodRegulation, substrates and functions of src
Brown, M. T., & Cooper, J. A. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(96)00003-0 · Cited by 1,172 · cited 2×
“Dysregulation of Src via post-translational modifications or genetic alterations leads to constitutive kinase activity and cellular transformation (reviewed in Bjorge et al., 1995; Brown and Cooper, 1996; Jove and Hanafusa, 1987; Martin, 2001; Taylor and Shalloway, 1996; Thomas and Brugge, 1997).”
BackgroundValidating clustering for gene expression data
Yeung, K. Y., Haynor, D. R., & Ruzzo, W. L. (2001) · Bioinformatics · doi:10.1093/bioinformatics/17.4.309 · Cited by 711 · cited 1×
“Figures of merit were calculated for various values of k as a measurement of cluster quality (Yeung et al., 2001).”
BackgroundMartin, G. S. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35073094 · Cited by 599
Sefton, B. M., Hunter, T., Beemon, K., & Eckhart, W. (1980) · Cell · doi:10.1016/0092-8674(80)90327-x · Cited by 546 · cited 1×
“Tyrosine kinase activity is low in normal fibroblasts (50.05% of total phosphorylated amino acids (Sefton et al., 1980)), and overexpression of pp60c-src generally does not grossly transform cells (Iba et al., 1984; Johnson et al., 1985; Parker et al., 1984; Shalloway et al., 1984).”
BackgroundInfluentialActivating SRC mutation in a subset of advanced human colon cancers
Irby, R. B., Mao, W., Coppola, D., Kang, J., Loubeau, J. M., Trudeau, W., Karl, R., Fujita, D. J., Jove, R., & Yeatman, T. J. (1999) · Nature Genetics · doi:10.1038/5971 · Cited by 489 · cited 5×
“Other activating mutations have been described that increase Src kinase activity and transforming potential, including a stop codon mutation at amino acid 531 (Irby et al., 1999; Jove et al., 1989; Kato et al., 1986; Levy et al., 1986).”
BackgroundMethodSelf-citationSecreted form of amyloid β protein precursor is involved in the growth regulation of fibroblasts
Saitoh, T., Sundsmo, M., Roch, J.-M., Kimura, N., Cole, G., Schubert, D., Oltersdorf, T., & Schenk, D. B. (1989) · Cell · doi:10.1016/0092-8674(89)90096-2 · Cited by 473 · cited 1×
“APP-1 was recently suggested to play a role in actin based cell motility (Sabo et al., 2001) and has been implicated in cell adhesion (Schubert et al., 1989) and proliferation (Saitoh et al., 1989).”
BackgroundCell Transformation by the Viral src Oncogene
Jove, R., & Hanafusa, H. (1987) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.03.110187.000335 · Cited by 401 · cited 1×
“Dysregulation of Src via post-translational modifications or genetic alterations leads to constitutive kinase activity and cellular transformation (reviewed in Bjorge et al., 1995; Brown and Cooper, 1996; Jove and Hanafusa, 1987; Martin, 2001; Taylor and Shalloway, 1996; Thomas and Brugge, 1997).”
BackgroundSelf-citationIncrease in activity and level of pp60c-src in progressive stages of human colorectal cancer.
Talamonti, M. S., Roh, M. S., Curley, S. A., & Gallick, G. E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116200 · Cited by 399 · cited 2×
“…activation has been implicated as an early event in colorectal carcinogenesis (Iravani et al., 1998), where over 80% of colon cancers have elevated Src activity (Talamonti et al., 1993), as well as in other gastrointestinal cancers (Kumble et al., 1997; Lutz et al., 1998; Takekura et al., 1990).”
BackgroundThe regulation of amyloid β protein precursor secretion and its modulatory role in cell adhesion
Schubert, D., Jin, L.-W., Saitoh, T., & Cole, G. (1989) · Neuron · doi:10.1016/0896-6273(89)90237-7 · Cited by 356 · cited 1×
“APP-1 was recently suggested to play a role in actin based cell motility (Sabo et al., 2001) and has been implicated in cell adhesion (Schubert et al., 1989) and proliferation (Saitoh et al., 1989).”
BackgroundThe TIGR Gene Indices: reconstruction and representation of expressed gene sequences
Quackenbush, J. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.141 · Cited by 342 · cited 2×
“We would also like to acknowledge the exceptional efforts of the TIGR Gene Indices Group as well as the TMEV software developers.”
MethodSelf-citationA genome-wide survey of RAS transformation targets
Zuber, J., Tchernitsa, O. I., Hinzmann, B., Schmitz, A.-C., Grips, M., Hellriegel, M., Sers, C., Rosenthal, A., & Schäfer, R. (2000) · Nature Genetics · doi:10.1038/72799 · Cited by 294 · cited 1×
“However, a systematic genome-wide assessment of downstream targets at the level of mRNA expression has not been forthcoming (but see Zuber et al., 2000).”
BackgroundOverexpression and Activation of the Tyrosine Kinase Src in Human Pancreatic Carcinoma
Lutz, M. P., Eßer, I. B. S., Flossmann-Kast, B. B. M., Vogelmann, R., Lührs, H., Friess, H., Büchler, M. W., & Adler, G. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.8043 · Cited by 249 · cited 2×
“…activation has been implicated as an early event in colorectal carcinogenesis (Iravani et al., 1998), where over 80% of colon cancers have elevated Src activity (Talamonti et al., 1993), as well as in other gastrointestinal cancers (Kumble et al., 1997; Lutz et al., 1998; Takekura et al., 1990).”
BackgroundSabo, S. L., Ikin, A. F., Buxbaum, J. D., & Greengard, P. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.7.1403 · Cited by 237 · cited 1×
“APP-1 was recently suggested to play a role in actin based cell motility (Sabo et al., 2001) and has been implicated in cell adhesion (Schubert et al., 1989) and proliferation (Saitoh et al., 1989).”
BackgroundIba, H., Takeya, T., Cross, F. R., Hanafusa, T., & Hanafusa, H. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.14.4424 · Cited by 230 · cited 1×
“Tyrosine kinase activity is low in normal fibroblasts (50.05% of total phosphorylated amino acids (Sefton et al., 1980)), and overexpression of pp60c-src generally does not grossly transform cells (Iba et al., 1984; Johnson et al., 1985; Parker et al., 1984; Shalloway et al., 1984).”
BackgroundInfluentialParker, R. C., Varmus, H. E., & Michael Bishop, J. (1984) · Cell · doi:10.1016/0092-8674(84)90308-8 · Cited by 189 · cited 2×
“The introduction of a single oncogene into established rodent fibroblast cell lines, is sufficient to produce transformation (Muschel et al., 1985; Parker et al., 1984).”
BackgroundInfluentialOverexpressed pp60c-src can induce focus formation without complete transformation of NIH 3T3 cells.
Johnson, P. J., Coussens, P. M., Danko, A. V., & Shalloway, D. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.5.1073 · Cited by 168 · cited 2×
“These differences render v-Src constitutively active and highly transforming. vSrc transformed cells, but not c-Src overexpressing cells, have the ability to form tumors in nude mice (Johnson et al., 1985).”
BackgroundInfluentialKato, J. Y., Takeya, T., Grandori, C., Iba, H., Levy, J. B., & Hanafusa, H. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.12.4155 · Cited by 164
Activation of the transforming potential of p60c-src by a single amino acid change.
Levy, J. B., Iba, H., & Hanafusa, H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4228 · Cited by 155 · cited 1×
“Other activating mutations have been described that increase Src kinase activity and transforming potential, including a stop codon mutation at amino acid 531 (Irby et al., 1999; Jove et al., 1989; Kato et al., 1986; Levy et al., 1986).”
BackgroundExpression of the insulin-like growth factors and their receptors in adenocarcinoma of the colon
Freier, S., Weiss, O., Eran, M., Flyvbjerg, A., Dahan, R., Nephesh, I., Safra, T., Shiloni, E., & Raz, I. (1999) · Gut · doi:10.1136/gut.44.5.704 · Cited by 150 · cited 1×
“Of these, only man-6-P/IGF-II receptor expression has been shown prior to our study to be elevated in malignant colon tissue (Freier et al., 1999).”
BackgroundCross-Referencing Eukaryotic Genomes: TIGR Orthologous Gene Alignments (TOGA)
Lee, Y., Sultana, R., Pertea, G., Cho, J., Karamycheva, S., Tsai, J., Parvizi, B., Cheung, F., Antonescu, V., White, J., et al. (2002) · Genome Research · doi:10.1101/gr.212002 · Cited by 150
Self-citationKraker, A. J., Hartl, B. G., Amar, A. M., Barvian, M. R., Showalter, H. D., & Moore, C. W. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00405-6 · Cited by 148 · cited 1×
“Reversed expression of Src regulated genes by a pharmacologic inhibitor We used the tyrosine kinase inhibitor, PD180970, a pyrido[2,3-d]pyrimidine ATP-competitive inhibitor of c-Src kinases (Kraker et al., 2000), to inhibit Src activity in Src531 M3.”
MethodNiinaka, Y., Paku, S., Haga, A., Watanabe, H., & Raz, A. (1998) · PubMed · Cited by 142
Overexpression of the c-src protein does not induce transformation of NIH 3T3 cells.
Shalloway, D. I., Coussens, P. M., & Yaciuk, P. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.22.7071 · Cited by 140 · cited 1×
“Tyrosine kinase activity is low in normal fibroblasts (50.05% of total phosphorylated amino acids (Sefton et al., 1980)), and overexpression of pp60c-src generally does not grossly transform cells (Iba et al., 1984; Johnson et al., 1985; Parker et al., 1984; Shalloway et al., 1984).”
BackgroundInfluentialTakeya, T., & Hanafusa, H. (1982) · Journal of Virology · doi:10.1128/jvi.44.1.12-18.1982 · Cited by 124 · cited 1×
“Cellular Src (c-Src) differs from the viral oncoprotein v-Src at a handful of amino acids throughout the protein and at the negative carboxy terminus where 19 critical amino acids of c-Src have been replaced with 12 unrelated amino acids in v-Src (Takeya and Hanafusa, 1982).”
BackgroundSkotzko, M. J., Wu, L., Anderson, W. F., Gordon, E. M., & Hall, F. L. (1995) · PubMed · Cited by 102
Lasp-1, a Novel Type of Actin-Binding Protein Accumulating in Cell Membrane Extensions
Schreiber, V., Moog-Lutz, C., Régnier, C. H., Chenard, M.-P., Boeuf, H., Vonesch, J.-L., Tomasetto, C., & Rio, M.-C. (1998) · Molecular Medicine · doi:10.1007/bf03401929 · Cited by 94 · cited 1×
“Lasp-1, a novel actin-binding protein that is amplified in breast tumors (Schreiber et al., 1998), is postulated to play an important role in the regulation of dynamic actin-based, cytoskeletal activities (Chew et al., 2000).”
BackgroundReimer, C. L., Borras, A. M., Kurdistani, S. K., Garreau, J. R., Chung, M., Aaronson, S. A., & Lee, S. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.11022 · Cited by 93 · cited 1×
“Cyclin G, up-regulated in our Duke’s D and metastasis samples, is also overexpressed in human osteosarcoma, breast and prostate cancer cells (Reimer et al., 1999; Skotzko et al., 1995).”
BackgroundMiller, L. D., Park, K. S., Guo, Q. M., Alkharouf, N. W., Malek, R. L., Lee, N. H., Liu, E. T., & Cheng, S.-Y. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.19.6626-6639.2001 · Cited by 88 · cited 1×
“Selection of clones for arraying is described elsewhere (Miller et al., 2001).”
BackgroundSelf-citationChew, C. S., Parente, J. A., Chen, X., Chaponnier, C., & Cameron, R. S. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.11.2035 · Cited by 87
Expression of hsp90 and cyclin D1 in human breast cancer
Yano, M., Naito, Z., Yokoyama, M., Shiraki, Y., Ishiwata, T., Inokuchi, M., & Asano, G. (1999) · Cancer Letters · doi:10.1016/s0304-3835(98)00338-3 · Cited by 86 · cited 1×
“Hsp90, and cyclin D1 transcripts are significantly higher in breast cancer tissues than in noncancer tissues (Yano et al., 1999).”
BackgroundSrc activation in malignant and premalignant epithelia of Barrett's esophagus
Kumble, S., Omary, M. B., Cartwright, C., & Triadafilopoulos, G. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9024288 · Cited by 72 · cited 2×
“…activation has been implicated as an early event in colorectal carcinogenesis (Iravani et al., 1998), where over 80% of colon cancers have elevated Src activity (Talamonti et al., 1993), as well as in other gastrointestinal cancers (Kumble et al., 1997; Lutz et al., 1998; Takekura et al., 1990).”
BackgroundSrc and the control of cell division
Taylor, S. J., & Shalloway, D. I. (1996) · BioEssays · doi:10.1002/bies.950180105 · Cited by 71 · cited 2×
“Dysregulation of Src via post-translational modifications or genetic alterations leads to constitutive kinase activity and cellular transformation (reviewed in Bjorge et al., 1995; Brown and Cooper, 1996; Jove and Hanafusa, 1987; Martin, 2001; Taylor and Shalloway, 1996; Thomas and Brugge, 1997).”
BackgroundFull Oncogenic Activities of v-Src Are Mediated by Multiple Signaling Pathways
Odajima, J., Matsumura, I., Sonoyama, J., Daino, H., Kawasaki, A., Tanaka, H., Inohara, N., Kitamura, T., Downward, J., Nakajima, K., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001606200 · Cited by 65 · cited 1×
“While full transforming ability of v-Src requires simultaneous activation of multiple signaling pathways (Odajima et al., 2000), we hypothesized that the c-Src, Src531 M14 and M18 lines expressing limited Src activity do not sufficiently activate the multiple pathways required for full…”
BackgroundStudler, J., Glowinski, J., & Lévi‐Strauss, M. (1993) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1993.tb00527.x · Cited by 61 · cited 1×
“We report the upregulation of D52 occurs in colon tumors and by cells overexpressing Src. P311 encodes an abundant embryonic brain protein of unknown function (Studler et al., 1993) and is upregulated in our colon tumor samples.”
BackgroundBjorge, J. D., Bellagamba, C., Cheng, H., Tanaka, A., Wang, J. H.-C., & Fujita, D. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.24222 · Cited by 61 · cited 1×
“Dysregulation of Src via post-translational modifications or genetic alterations leads to constitutive kinase activity and cellular transformation (reviewed in Bjorge et al., 1995; Brown and Cooper, 1996; Jove and Hanafusa, 1987; Martin, 2001; Taylor and Shalloway, 1996; Thomas and Brugge, 1997).”
BackgroundDecrease in membrane-associated actin of fibroblasts after transformation by Rous sarcoma virus.
Wickus, G. G., Gruenstein, E., Robbins, P. W., & Rich, A. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.2.746 · Cited by 59 · cited 1×
“…transport are overexpressed in tumors Transformation of eukaryotic cells by Src is associated with alterations in cytoskeletal organization (Wickus et al., 1975). v-Src transformed 3Y1 fibroblasts have poorly organized stress fibers and reduced amounts of a actin (Okamoto-Inoue et al.,…”
BackgroundElevated c-Src protein expression is an early event in colonic neoplasia.
Iravani, S., Mao, W., Fu, L., Karl, R. C., Yeatman, T., Jove, R., & Coppola, D. (1998) · PubMed · Cited by 57
Self-citationAkamatsu, H., Ichihara-Tanaka, K., Ozono, K., Kamiike, W., Matsuda, H., & Sekiguchi, K. (1996) · PubMed · Cited by 55
Lee, N. H., & Malek, R. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.35.22317 · Cited by 37 · cited 1×
“Cells were grown in 100 mm tissue culture dishes to 75% confluency, harvested/lysed in 958C SDS–PAGE sample buffer and proteins were separated as described previously (Lee and Malek, 1998).”
MethodSelf-citationManenti, S., Malecaze, F., Chap, H., & Darbon, J. M. (1998) · PubMed · Cited by 34
pp60c‐src protein kinase activity in human gastric carcinomas
Takekura, N., Yasui, W., Yoshida, K., Tsujino, T., Nakayama, H., Kameda, T., Yokozaki, H., Ishimura, Y., Ito, H., & Tahara, E. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910450510 · Cited by 34 · cited 1×
“…activation has been implicated as an early event in colorectal carcinogenesis (Iravani et al., 1998), where over 80% of colon cancers have elevated Src activity (Talamonti et al., 1993), as well as in other gastrointestinal cancers (Kumble et al., 1997; Lutz et al., 1998; Takekura et al., 1990).”
BackgroundSuppression of anchorage-independent growth of human cancer cell lines by the drs gene
Yamashita, A., Hakura, A., & Inoue, H. (1999) · Oncogene · doi:10.1038/sj.onc.1202852 · Cited by 34 · cited 1×
“Of note, drs suppresses v-Src transformation in fibroblasts (Inoue et al., 1998) and suppresses anchorage-independent growth in a variety of human cancer cell lines (Yamashita et al., 1999).”
BackgroundAlteration in expression of smooth muscle α-Actin associated with transformation of rat 3Y1 cells
Okamoto-Inoue, M., Taniguchi, S., Ano, H. S., 川野, 豊., Kimura, G., Gabbiani, G., & Baba, T. (1990) · Journal of Cell Science · doi:10.1242/jcs.96.4.631 · Cited by 29
Suppression of v- src Transformation by the drs Gene
Inoue, H., Pan, J., & Hakura, A. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2532-2537.1998 · Cited by 28 · cited 1×
“Of note, drs suppresses v-Src transformation in fibroblasts (Inoue et al., 1998) and suppresses anchorage-independent growth in a variety of human cancer cell lines (Yamashita et al., 1999).”
BackgroundKato, J., Takeya, T., Grandori, C., Iba, H., Levy, J. B., & Hanafusa, H. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.12.4155-4160.1986 · Cited by 18 · cited 1×
“Other activating mutations have been described that increase Src kinase activity and transforming potential, including a stop codon mutation at amino acid 531 (Irby et al., 1999; Jove et al., 1989; Kato et al., 1986; Levy et al., 1986).”
Background
Cited by
TM4: a free, open-source system for microarray data management and analysis
Saeed, A. I., Sharov, V., White, J., Li, J., Liang, W., Bhagabati, N., Braisted, J., Klapa, M., Currier, T., Thiagarajan, M., et al. (2003) · BioTechniques · doi:10.2144/03342mt01 · Cited by 4,837
Self-citationYeatman, T. J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1366 · Cited by 1,113
Self-citationSrc family kinases in tumor progression and metastasis
Summy, J. M., & Gallick, G. E. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1023772912750 · Cited by 827
“[66] recently used gene chip technology to compare the expression of genes in human colon cancer cells to those induced in Src-transformed rat fibroblasts.”
MethodSrc kinases as therapeutic targets for cancer
Kim, L. C., Song, L., & Haura, E. B. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.129 · Cited by 700
“PD180970 can suppress cell growth and survival via inhibition of Src in multiple cancers, such as lung, melanoma, and colon”
BackgroundNewest findings on the oldest oncogene; how activated src does it
Frame, M. C. (2004) · Journal of Cell Science · doi:10.1242/jcs.01111 · Cited by 367
“Since Src is often upregulated during the metastatic transition in colon cancers, for example in the Fidler model of colorectal metastasis (Jones et al., 2002; Mao et al., 1997), evaluating its mode of de-regulating the E-cadherin tumour suppressor protein might lead to new therapeutic targets.”
Background
Metadata
- Authors
- Malek, R. L., Irby, R. B., Guo, Q. M., Lee, K., Wong, S., He, M., Tsai, J., Frank, B., Liu, E. T., Quackenbush, J., Jove, R., Yeatman, T. J., & Lee, N. H.
- Affiliations
- University of South Florida (US)
- Johns Hopkins University (US)
- National Institutes of Health (US)
- Corresponding author
- Yeatman, Timothy J
- Lee, Norman H
- Venue
- Oncogene
- Published
- 2002-10-09
- Volume
- 21
- Issue
- 47
- Pages
- 7256-7265
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2004903465
- Cited by
- 81
- References
- 50
- Citations by year
- 2025: 1 · 2024: 1 · 2022: 1 · 2021: 3 · 2019: 4 · 2018: 1 · 2017: 5 · 2016: 2 · 2015: 1 · 2014: 3 · 2013: 4 · 2012: 2
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- National Institutes of Health (5r01ca077049-02, 5r01hl059781-02)
- U.S. Public Health Service (6120-119-L0-A)
- National Heart, Lung, and Blood Institute (HL-59781)
- National Cancer Institute (K24CA085429, CA85429-01, U01CA085052, CA77049-02, CA85052-A1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- Src kinase, colon cancer, cell transformation, gene expression profiling, tumor progression, cell cycle genes, cytoskeletal proteins, transcription factors, lysosomal proteins, oncogene activation
- MeSH terms
- Animals, Cell Line, Transformed, Cell Transformation, Neoplastic, Colonic Neoplasms, Humans, Pyridones, Pyrimidines, Up-Regulation, Gene Expression Regulation, Neoplastic, Cluster Analysis, Genes, src, Reverse Transcriptase Polymerase Chain Reaction, Gene Expression Profiling, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.